Physician profile
Adam J Teichman
NPI 1043203656
$544,592.69
in general payments reported to CMS, 2019-2025
37 companies · $54K in 2025
The $54K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $32K · 2021: $46K · 2022: $162K · 2023: $127K · 2024: $66K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $122K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $69K · Travel and Lodging: $44K · Food and Beverage: $11K · Entertainment: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $121,997.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $68,972.50 |
| Travel and Lodging | $44,450.39 |
| Food and Beverage | $10,890.25 |
| Entertainment | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $223,859.94 | 2019-2025 | Affinity, Puraply Wound Matrix, Puraply |
| Averitas Pharma INC. | $177,360.24 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $132,104.69 | 2021-2025 | Qutenza |
| Stryker Corporation | $3,694.09 | 2019-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Prostep Mica |
| Horizon Therapeutics Plc | $1,848.48 | 2019-2022 | |
| Convatec INC. | $1,694.69 | 2022-2025 | |
| Smith+Nephew, INC. | $1,459.91 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Nevro Corp. | $425.98 | 2019-2024 | Senza |
| Next Science LLC | $392.46 | 2023-2025 | Xperience, Blastx, Surgx |
| Reapplix INC. | $345.73 | 2022-2023 | 3c Patch Kit - Box |
| Paratek Pharmaceuticals, INC. | $175.03 | 2021-2023 | Nuzyra |
| Kerecis Limited | $163.16 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Globus Medical, INC. | $155.84 | 2021-2025 | Senza |
| Stability Biologics, LLC | $135.00 | 2025 | |
| Treace Medical Concepts, INC. | $119.74 | 2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $59.32 | 2021 | |
| Misonix INC | $57.33 | 2021 | |
| Novus Surgical Solutions LLC | $55.44 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $53.60 | 2019-2023 | |
| Melinta Therapeutics, LLC | $41.92 | 2019 | |
| Axogen | $40.11 | 2019 | |
| Boston Scientific Corporation | $39.21 | 2025 | Wavewriter Alpha Prime 16 |
| Cashflow Solutions, LLC | $38.67 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Depuy Synthes Sales INC. | $38.53 | 2019 | |
| Kci USA, INC. | $35.56 | 2020-2023 | V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Ibsa Pharma INC. | $24.49 | 2025 | Flector, Tirosint, Licart |
| Vertex Pharmaceuticals Incorporated | $24.11 | 2024 | |
| Reddress USA, INC. | $23.90 | 2021 | |
| Urgo Medical North America, LLC | $20.45 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Kowa Pharmaceuticals America, INC. | $18.49 | 2023 | Seglentis |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.50 | 2022 | |
| Bone Support INC. | $14.22 | 2025 | Ceramentbone Void Filler, Cerament G |
| Merck Sharp & Dohme LLC | $13.48 | 2019 | |
| Electronic Waveform Lab, INC. | $12.78 | 2020 | |
| Synergy Orthopedics, LLC | $11.95 | 2022 | |
| Ermi LLC | $10.44 | 2020 | |
| Orthofix Medical, INC. | $6.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Teichman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.